Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesISMRM 2026ISMRM: DWI kurtosis approach predicts breast cancer treatment responseA DWI approach using diffusion kurtosis showed success in predicting early treatment response in breast cancer patients.ISMRM 2026ISMRM: F-18 PSMA-1007 outperforms Ga-68 PSMA-11 at low PSA levelsISMRM 2026ISMRM: 3D amplified MRI reveals age-related drop in brain pulsatilityISMRM 2026ISMRM: MRI, MRS show metabolic gains from obesity lifestyle interventionSponsor ContentRadiology is Under Pressure
